SlideShare a Scribd company logo
1 of 50
RobOKoD: microbial strain design for
(over)production of target
compounds.
Natalie J Stanford, Pierre Millard, Neil Swainston.
RobOKoD = Robust, Optimisation, Knockout, and
Dampening.
Gene addition
KO/Over-expression?
Conditions?
Current methods for microbial strain design are
limited.
…this makes engineering strains difficult, time
consuming, and expensive.
Computational approaches allow us to explore different
strategies quickly, leading to more effective cell design.
Condition
selection.
Gene
addition
KO selection/Over-
expression
Iterative
selection
Condition
selection.
Gene
addition
KO selection/Over-
expression
Iterative
selection
First we need to modify the reconstructed cell so
that, in theory, it can produce the target.
First we need to modify the reconstructed cell so
that, in theory, it can produce the target.
Condition
selection.
Gene
addition
KO selection/Over-
expression
Iterative
selection
Gene addition/
KO selection.
Gene addition.
Input
Growt
h
Target
Checked using:
• Flux Balance
Analysis
How is Flux Balance Analysis (FBA) used to verify that
the target can be produced?
Flux Balance Analysis allows us to compute feasible
cellular flux distributions.
Growth
Defined nutrient
input
Target
10
Growth
Defined nutrient
input
Target
10 Objective =
Max Growth
Flux Balance Analysis allows us to compute feasible
cellular flux distributions.
Growth
Defined nutrient
input
Target
10 Objective =
Max Growth
10
10
10
10
Flux Balance Analysis allows us to compute feasible
cellular flux distributions.
Growth
Defined nutrient
input
Target
10 Objective =
Max Growth
10
10
10
10
Flux Balance Analysis allows us to compute feasible
cellular flux distributions.
Growth
Defined nutrient
input
Target
10 Objective =
Max target
We can verify whether the target can be produced
from gene additions using FBA.
Growth
Defined nutrient
input
Target
10 Objective =
Max target
10
10
We can verify whether the target can be produced
from gene additions using FBA.
We can also verify whether it is possible for the cells
to remain viable whilst producing target.
Growth
Defined nutrient
input
Target
10 Objective =
Max Both
Growth
Defined nutrient
input
Target
10 Objective =
Max Both
10
5
5
5
5
We can also verify whether it is possible for the cells
to remain viable whilst producing target.
Condition
selection.
Gene addition/
KO selection.
Over-
expression
Iterative
selection
Over-
expression
RobOKoD (Robust
Overexpression, Knockout and
Dampening
Condition
selection.
Condition selection.
• Could be
identified
using
phenotypic
phase
plane
analysis.
Gene addition/
KO selection.
Gene addition/
KO selection.Checked using:
• FBA
Gene addition.
Gene
addition
Gene addition/
KO selection.
Gene addition.
Input
Growt
h
butanol
Checked using:
• Flux Balance
Analysis
• Looked at Flux variability
profiles to see which
reactions were important.
• Identified competing
reactions.
RobOKoD uses two principles in its strain design.
1. To improve target production network changes should
reduce carbon loss to peripheral pathway,
2. Flux Variability of each reaction will differ depending on
whether the reaction is important for growth, generating
the desired product, both, or neither.
We use Flux Variability Profiling (FVAp), which
relies on Flux Variability Analysis (FVA).
As we saw in the earlier example, growth can use
two different pathways.
Growth
Defined nutrient
input
target
10 Objective =
Max Growth
Growth
Defined nutrient
input
target
10 Objective =
Max Growth
Max flux
Min flux.
Flux variability analysis shows us the minimum and
maximum flux each reaction can carry, providing the right
combination of other reactions are in place.
Growth
Defined nutrient
input
target
10/10 Objective =
Max Growth
10/0
10/0
10/0
10/10
10/0
10/0
10/0
Max flux
Min flux.
Flux variability analysis shows us the minimum and
maximum flux each reaction can carry, providing the right
combination of other reactions are in place.
We can use this to identify reactions that are important for
generating the target, and those that compete.
Growth
Defined nutrient
input
target
10
Max flux
Min flux.
Objective:
Max target subject to
4 units of growth
4
Growth
Defined nutrient
input
target
10/10
Max flux
Min flux.
Objective:
Max target subject to
4 units of growth
4/4
10/6
4/0
4/0
4/0
4/0
4/0
6/6
We can use this to identify reactions that are important for
generating the target, and those that compete.
Growth
Defined nutrient
input
target
10/10
Max flux
Min flux.
Objective:
Max target subject to
4 units of growth
4/4
10/6
4/0
4/0
4/0
4/0
4/0
6/6
We can use this to identify reactions that are important for
generating the target, and those that compete.
Growth
Defined nutrient
input
target
10/10
Max flux
Min flux.
Objective:
Max target subject to
4 units of growth
4/4
10/6
4/0
4/0
4/0
4/0
4/0
6/6
We could use this to identify reactions that were important
for generating butanol, and those that competed.
Building the FVAp Part 1:
Optimising target, subject to fixed amounts of
growth.
Growth
Defined
nutrient
input
target
Max flux
Min flux.
Objective: Max
target subject to
2.5 units of fixed
growth.
2.5
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
10
10
10
Growth
Defined
nutrient
input
target
Max flux
Min flux.
2.5
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
2.5/0
10
2.5/0
10/7.5
7.5
2.5/0
2.5/0
2.5/0
10
10
Objective: Max
target subject to
2.5 units of fixed
growth.
Growth
Defined
nutrient
input
target
Max flux
Min flux.
510
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux10
10
Objective: Max
target subject to 5
units of fixed
growth.
Growth
Defined
nutrient
input
target
Max flux
Min flux.
5
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
5/0
10
5/0
10/5
5
5/0
5/0
5/0
10
10
Objective: Max
target subject to 5
units of fixed
growth.
Growth
Defined
nutrient
input
target
Max flux
Min flux.
10
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
10
10
10
Objective: Max
target subject to 10
units of fixed
growth.
Growth
Defined
nutrient
input
target
Max flux
Min flux.
10
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
10/0
10
10/0
10/0
0/0
10/0
10/0
10/0
10
10
Objective: Max
target subject to 10
units of fixed
growth.
Building the FVAp Part 2:
Optimising growth, subject to fixed amounts of
target.
Growth
Defined
nutrient
input
target
Max flux
Min flux.
2.5
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
10
10
10
Objective: Max
growth subject to
2.5 units of fixed
target.
Growth
Defined
nutrient
input
target
Max flux
Min flux.
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
7.5/0
10
7.5/0
10/2.5
7.5/0
7.5/0
10
10
2.5
7.5
7.5/0
Objective: Max
growth subject to
2.5 units of fixed
target.
Growth
Defined
nutrient
input
target
Max flux
Min flux.
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
10
10
10
7.5
Objective: Max
growth subject to
7.5 units of fixed
target.
Growth
Defined
nutrient
input
target
Max flux
Min flux.
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
10
10
10
7.5
Objective: Max
growth subject to
7.5 units of fixed
target.
2.5/0
2.5/0
2.5/0
2.5
10/7.5
2.5/0
2.5/0
Growth
Defined
nutrient
input
target
Max flux
Min flux.
100% Target 100% Growth
Flux
100% Target 100% Growth
Flux
10
10
10
10
Objective: Max
growth subject to
10 units of fixed
target.
0
0
0
0
10/10
0
2.5/0
In more complicated networks there is more nuance
in the reaction profiles.
Knockouts profiles show an increase in flux as we
move towards maximal growth.
Opt Target
Fixed growth.
Opt growth
Fixed target.
Strong overexpressions show a decrease in flux as we
move towards optimal growth.
Opt Target
Fixed growth.
Opt growth
Fixed target.
Weak overexpressions flux advantages for the target.
Opt Target
Fixed growth.
Opt growth
Fixed target.
Dampenings show flux disadvantages for the target.
Opt Target
Fixed growth.
Opt growth
Fixed target.
Testing RobOKoD.
A successful strain of butanol producing E.coli was
designed in 2011.
Reverse beta
Oxidation cycle
Anoxic conditions.
We predicted 4 knockouts, and anoxic conditions
were required to generate butanol.
The strain we predicted using these techniques showed
modified functions that were similar to the laboratory
engineered strain.
And the production of butanol was closer to that in
the experimental strain.
RobOKoD: microbial strain design for (over)production of target compounds.

More Related Content

Similar to RobOKoD: microbial strain design for (over)production of target compounds.

Genetik technical report (1)
Genetik technical report (1)Genetik technical report (1)
Genetik technical report (1)yep shi qi
 
Development of chemoenzymatic process.pptx
Development of chemoenzymatic process.pptxDevelopment of chemoenzymatic process.pptx
Development of chemoenzymatic process.pptxrajeshkumar590473
 
JBEI Research Highlights - January 2017
JBEI Research Highlights - January 2017JBEI Research Highlights - January 2017
JBEI Research Highlights - January 2017Irina Silva
 
Aa256 bio flocelligen115_sf9
Aa256 bio flocelligen115_sf9Aa256 bio flocelligen115_sf9
Aa256 bio flocelligen115_sf9Duc Nguyen Manh
 
Aa256 bio flocelligen115_sf9_2
Aa256 bio flocelligen115_sf9_2Aa256 bio flocelligen115_sf9_2
Aa256 bio flocelligen115_sf9_2Duc Nguyen Manh
 
One-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioOne-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioGenScript ProBio
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformMilliporeSigma
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformMerck Life Sciences
 
Best compound characterization protocol
Best compound characterization protocolBest compound characterization protocol
Best compound characterization protocolWenlan Hu
 
Low cost nutraceutical hypothesis testing
Low cost nutraceutical hypothesis testingLow cost nutraceutical hypothesis testing
Low cost nutraceutical hypothesis testingWenlan Hu
 
Biopharmaceutical Process Development: Good Manufacturing Practices or Breaki...
Biopharmaceutical Process Development: Good Manufacturing Practices or Breaki...Biopharmaceutical Process Development: Good Manufacturing Practices or Breaki...
Biopharmaceutical Process Development: Good Manufacturing Practices or Breaki...Chris Willmott
 
Aviwell Seed Pitch Deck
Aviwell Seed Pitch DeckAviwell Seed Pitch Deck
Aviwell Seed Pitch Decksjcobrien
 
2024.03.12 Cost drivers of cultivated meat production.pdf
2024.03.12 Cost drivers of cultivated meat production.pdf2024.03.12 Cost drivers of cultivated meat production.pdf
2024.03.12 Cost drivers of cultivated meat production.pdfThe Good Food Institute
 
Finding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging DrugsFinding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging DrugsWenlan Hu
 
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystemsCRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystemsWenlan Hu
 
JBEI August 2020 Highlights
JBEI August 2020 HighlightsJBEI August 2020 Highlights
JBEI August 2020 HighlightsLeahFreemanSloan
 
MAKING HEALTHCARE MORE ACCESSIBLE
MAKING HEALTHCARE MORE ACCESSIBLEMAKING HEALTHCARE MORE ACCESSIBLE
MAKING HEALTHCARE MORE ACCESSIBLEiQHub
 

Similar to RobOKoD: microbial strain design for (over)production of target compounds. (20)

High-performing CHO cell lines
High-performing CHO cell lines High-performing CHO cell lines
High-performing CHO cell lines
 
Genetik technical report (1)
Genetik technical report (1)Genetik technical report (1)
Genetik technical report (1)
 
Cultivated meat cost curve.pdf
Cultivated meat cost curve.pdfCultivated meat cost curve.pdf
Cultivated meat cost curve.pdf
 
Development of chemoenzymatic process.pptx
Development of chemoenzymatic process.pptxDevelopment of chemoenzymatic process.pptx
Development of chemoenzymatic process.pptx
 
JBEI Research Highlights - January 2017
JBEI Research Highlights - January 2017JBEI Research Highlights - January 2017
JBEI Research Highlights - January 2017
 
Aa256 bio flocelligen115_sf9
Aa256 bio flocelligen115_sf9Aa256 bio flocelligen115_sf9
Aa256 bio flocelligen115_sf9
 
Aa256 bio flocelligen115_sf9_2
Aa256 bio flocelligen115_sf9_2Aa256 bio flocelligen115_sf9_2
Aa256 bio flocelligen115_sf9_2
 
One-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioOne-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBio
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train Platform
 
The Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train PlatformThe Biocontinuum™ Seed Train Platform
The Biocontinuum™ Seed Train Platform
 
Best compound characterization protocol
Best compound characterization protocolBest compound characterization protocol
Best compound characterization protocol
 
Low cost nutraceutical hypothesis testing
Low cost nutraceutical hypothesis testingLow cost nutraceutical hypothesis testing
Low cost nutraceutical hypothesis testing
 
Biopharmaceutical Process Development: Good Manufacturing Practices or Breaki...
Biopharmaceutical Process Development: Good Manufacturing Practices or Breaki...Biopharmaceutical Process Development: Good Manufacturing Practices or Breaki...
Biopharmaceutical Process Development: Good Manufacturing Practices or Breaki...
 
Aviwell Seed Pitch Deck
Aviwell Seed Pitch DeckAviwell Seed Pitch Deck
Aviwell Seed Pitch Deck
 
2024.03.12 Cost drivers of cultivated meat production.pdf
2024.03.12 Cost drivers of cultivated meat production.pdf2024.03.12 Cost drivers of cultivated meat production.pdf
2024.03.12 Cost drivers of cultivated meat production.pdf
 
Valitacell Technology
Valitacell TechnologyValitacell Technology
Valitacell Technology
 
Finding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging DrugsFinding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging Drugs
 
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystemsCRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
CRO Company for Mode of Action & Efficacy Test for Drugs | InvivoBiosystems
 
JBEI August 2020 Highlights
JBEI August 2020 HighlightsJBEI August 2020 Highlights
JBEI August 2020 Highlights
 
MAKING HEALTHCARE MORE ACCESSIBLE
MAKING HEALTHCARE MORE ACCESSIBLEMAKING HEALTHCARE MORE ACCESSIBLE
MAKING HEALTHCARE MORE ACCESSIBLE
 

Recently uploaded

Manganese‐RichSandstonesasanIndicatorofAncientOxic LakeWaterConditionsinGale...
Manganese‐RichSandstonesasanIndicatorofAncientOxic  LakeWaterConditionsinGale...Manganese‐RichSandstonesasanIndicatorofAncientOxic  LakeWaterConditionsinGale...
Manganese‐RichSandstonesasanIndicatorofAncientOxic LakeWaterConditionsinGale...Sérgio Sacani
 
Factor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary GlandFactor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary GlandRcvets
 
GBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolationGBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolationAreesha Ahmad
 
GBSN - Microbiology (Unit 4) Concept of Asepsis
GBSN - Microbiology (Unit 4) Concept of AsepsisGBSN - Microbiology (Unit 4) Concept of Asepsis
GBSN - Microbiology (Unit 4) Concept of AsepsisAreesha Ahmad
 
Heads-Up Multitasker: CHI 2024 Presentation.pdf
Heads-Up Multitasker: CHI 2024 Presentation.pdfHeads-Up Multitasker: CHI 2024 Presentation.pdf
Heads-Up Multitasker: CHI 2024 Presentation.pdfbyp19971001
 
ANATOMY OF DICOT AND MONOCOT LEAVES.pptx
ANATOMY OF DICOT AND MONOCOT LEAVES.pptxANATOMY OF DICOT AND MONOCOT LEAVES.pptx
ANATOMY OF DICOT AND MONOCOT LEAVES.pptxRASHMI M G
 
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptxSaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptxPat (JS) Heslop-Harrison
 
Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...
Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...
Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...kevin8smith
 
Polyethylene and its polymerization.pptx
Polyethylene and its polymerization.pptxPolyethylene and its polymerization.pptx
Polyethylene and its polymerization.pptxMuhammadRazzaq31
 
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptxNanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptxssusera4ec7b
 
dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...
dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...
dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...dkNET
 
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...Ansari Aashif Raza Mohd Imtiyaz
 
MSCII_ FCT UNIT 5 TOXICOLOGY.pdf
MSCII_              FCT UNIT 5 TOXICOLOGY.pdfMSCII_              FCT UNIT 5 TOXICOLOGY.pdf
MSCII_ FCT UNIT 5 TOXICOLOGY.pdfSuchita Rawat
 
Taphonomy and Quality of the Fossil Record
Taphonomy and Quality of the  Fossil RecordTaphonomy and Quality of the  Fossil Record
Taphonomy and Quality of the Fossil RecordSangram Sahoo
 
EU START PROJECT. START-Newsletter_Issue_4.pdf
EU START PROJECT. START-Newsletter_Issue_4.pdfEU START PROJECT. START-Newsletter_Issue_4.pdf
EU START PROJECT. START-Newsletter_Issue_4.pdfStart Project
 
GBSN - Biochemistry (Unit 8) Enzymology
GBSN - Biochemistry (Unit 8) EnzymologyGBSN - Biochemistry (Unit 8) Enzymology
GBSN - Biochemistry (Unit 8) EnzymologyAreesha Ahmad
 
MSC IV_Forensic medicine - Mechanical injuries.pdf
MSC IV_Forensic medicine - Mechanical injuries.pdfMSC IV_Forensic medicine - Mechanical injuries.pdf
MSC IV_Forensic medicine - Mechanical injuries.pdfSuchita Rawat
 
Classification of Kerogen, Perspective on palynofacies in depositional envi...
Classification of Kerogen,  Perspective on palynofacies in depositional  envi...Classification of Kerogen,  Perspective on palynofacies in depositional  envi...
Classification of Kerogen, Perspective on palynofacies in depositional envi...Sangram Sahoo
 

Recently uploaded (20)

Manganese‐RichSandstonesasanIndicatorofAncientOxic LakeWaterConditionsinGale...
Manganese‐RichSandstonesasanIndicatorofAncientOxic  LakeWaterConditionsinGale...Manganese‐RichSandstonesasanIndicatorofAncientOxic  LakeWaterConditionsinGale...
Manganese‐RichSandstonesasanIndicatorofAncientOxic LakeWaterConditionsinGale...
 
Factor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary GlandFactor Causing low production and physiology of mamary Gland
Factor Causing low production and physiology of mamary Gland
 
GBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolationGBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolation
 
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
 
GBSN - Microbiology (Unit 4) Concept of Asepsis
GBSN - Microbiology (Unit 4) Concept of AsepsisGBSN - Microbiology (Unit 4) Concept of Asepsis
GBSN - Microbiology (Unit 4) Concept of Asepsis
 
Heads-Up Multitasker: CHI 2024 Presentation.pdf
Heads-Up Multitasker: CHI 2024 Presentation.pdfHeads-Up Multitasker: CHI 2024 Presentation.pdf
Heads-Up Multitasker: CHI 2024 Presentation.pdf
 
ANATOMY OF DICOT AND MONOCOT LEAVES.pptx
ANATOMY OF DICOT AND MONOCOT LEAVES.pptxANATOMY OF DICOT AND MONOCOT LEAVES.pptx
ANATOMY OF DICOT AND MONOCOT LEAVES.pptx
 
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptxSaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
 
Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...
Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...
Harry Coumnas Thinks That Human Teleportation is Possible in Quantum Mechanic...
 
Polyethylene and its polymerization.pptx
Polyethylene and its polymerization.pptxPolyethylene and its polymerization.pptx
Polyethylene and its polymerization.pptx
 
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptxNanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
Nanoparticles for the Treatment of Alzheimer’s Disease_102718.pptx
 
dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...
dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...
dkNET Webinar: The 4DN Data Portal - Data, Resources and Tools to Help Elucid...
 
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
Molecular and Cellular Mechanism of Action of Hormones such as Growth Hormone...
 
MSCII_ FCT UNIT 5 TOXICOLOGY.pdf
MSCII_              FCT UNIT 5 TOXICOLOGY.pdfMSCII_              FCT UNIT 5 TOXICOLOGY.pdf
MSCII_ FCT UNIT 5 TOXICOLOGY.pdf
 
Taphonomy and Quality of the Fossil Record
Taphonomy and Quality of the  Fossil RecordTaphonomy and Quality of the  Fossil Record
Taphonomy and Quality of the Fossil Record
 
EU START PROJECT. START-Newsletter_Issue_4.pdf
EU START PROJECT. START-Newsletter_Issue_4.pdfEU START PROJECT. START-Newsletter_Issue_4.pdf
EU START PROJECT. START-Newsletter_Issue_4.pdf
 
GBSN - Biochemistry (Unit 8) Enzymology
GBSN - Biochemistry (Unit 8) EnzymologyGBSN - Biochemistry (Unit 8) Enzymology
GBSN - Biochemistry (Unit 8) Enzymology
 
MSC IV_Forensic medicine - Mechanical injuries.pdf
MSC IV_Forensic medicine - Mechanical injuries.pdfMSC IV_Forensic medicine - Mechanical injuries.pdf
MSC IV_Forensic medicine - Mechanical injuries.pdf
 
ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY // USES OF ANTIOBIOTICS TYPES OF ANTIB...
ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY  // USES OF ANTIOBIOTICS TYPES OF ANTIB...ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY  // USES OF ANTIOBIOTICS TYPES OF ANTIB...
ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY // USES OF ANTIOBIOTICS TYPES OF ANTIB...
 
Classification of Kerogen, Perspective on palynofacies in depositional envi...
Classification of Kerogen,  Perspective on palynofacies in depositional  envi...Classification of Kerogen,  Perspective on palynofacies in depositional  envi...
Classification of Kerogen, Perspective on palynofacies in depositional envi...
 

RobOKoD: microbial strain design for (over)production of target compounds.